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1. Introduction 
Elongation factor G (EF-G) is a large protein con- 
sisting of one polypeptide chain with MI - 80 000. 
Studies of this protein by traditional methods used to 
determine the primary structure did not seem the 
most rational. We chose the method of limited prote- 
olysis as the first stage of studies permitting, in many 
cases, cleavage of the protein molecule into a small 
number of large fragments relatively stable against 
further effects of protease. On mild tryptic hydro- 
lysis the G-factor is split into 5 fragments [ 1, cf. 2,3], 
4 of which (T,-T,) form the complete protein poly 
peptide chain (for fragment nomenclature and arrange- 
ment in the protein chain see fig.1). Thus, the studies 
of the primary structure of the elongation factor G 
led to determination of the structure of these 4 frag- 
ments and a search for the overlapping peptides for 
reconstitution of the entire polypeptide chain. 
Studies of the structure of fragments TS-T, were 
relatively simple due to their comparatively ow mol- 
ecular mass. The molecular mass of the N-terminal 
fragment T6 is 6500, that of the following fragment 
T,, 7500, and that of the C-terminal fragment Ts, 
25 000. Traditional chemical and enzymatic methods 
of polypeptide chain cleavage permitted us earlier to 
determine the complete primary structures of frag- 
ments Tb [4], T, [5,6] and Ts [7] involving a total of 
>350 amino acid residues. 
To elucidate the complete structure of elongation 
factor G it was necessary to determine the ammo acid 
sequence of the largest ryptic fragment T4 represent- 
ing the middle part of the protein molecule and to 
obtain the peptides joining all the fragments oflimited 
trypsinolysis into a 1 polypeptide chain. To this end, 
the products of protein cleavage by cyanogen bromide 
and those of limited acidic hydrolysis at the Asp-Pro 
bond were studied. 
This paper is devoted to the results of these studies 
which permitted us to join all the fragments oflimited 
trypsinolysis nto one polypeptide chain and to present 
the complete amirmacid sequence of the elongation 
factor G. 
2. Materials and methods 
Elongation factor G and the mixture of fragments 
TJ and T, were isolated using the technique in [2]. 
The mixture of fragments T3 and T4 was used here 
without separation as fragment T, differs from frag- 
ment Ta by the presence at the N-terminus of the 
latter of the T, polypeptide chain. Homogeneity of 
the protein as well as the absence of any contamina- 
tions of other fragments in the mixture of fragments 
TJ and T4 was checked by SDS-polyacrylamide gel 
electrophoresis and by determination of the N-ter- 
minal ammo acid sequences by automated Edman 
degradation. 
To establish the structure of fragment T4 and to 
obtain overlappings between fragments of limited 
proteolysis, the products of cyanogen bromide cleav- 
age of a whole molecule of the G-factor were studied. 
For overlapping of cyanogen bromide peptides, the 
mixture of fragments Ta and T, was digested by tryp 
sin (TPCK-treated, Worthington) after modification 
of the fragments with maleic anhydride, by Staphylo- 
coccus aureus protease (Miles-Lab.) and by cleavage 
of the G-factor at the Asp-Pro bond [8]. 
After initial separation on Sephadex G-25 the pep 
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tides of cyanogen bromide cleavage were separated on 
QAESephadex A-25. Large cyanogen bromide and 
tryptic peptides were subjected to additional diges- 
tions with trypsin, chymotrypsin and Staph. uureus 
protease to determine their structure. The digests 
were separated by peptide mapping on cellulose thin- 
layer plates (Merck) or by high-performance liquid 
chromatography on sulphopolystyrene cation- 
exchange resin (Chromobeads type P, Technicon) 
with fluorescent detection of peptides in the eluate 
by o-phthalic dialdehyde (Sigma) [9]. To isolate pep 
tides of cyanogen bromide cleavage containing cys- 
teine residues, we used covalent chromatography on 
thiol-activated Sepharose 4B (Pharmacia) [lo]. 
C-Terminal ammo acid residues in fragment T, and 
in the isolated peptides were determined by carboxy- 
peptidases A, B (Worthington) [ 111 and Y [ 121 (iso- 
lated as in [ 131). 
The ammo acid composition was assessed on the 
D500 analyzer (Durrrum). The amount of valine and 
isoleucine was estimated after 72 h hydrolysis. 
Automated etermination of the amino acid 
sequences was done on a sequencer (model 89OC, 
Beckman) using the dhnethylallylamine or quadrol 
programs and on a solid-phase sequencer APS240 
(Bank-Hilger). Automated Edman degradation used 
for analysis of the peptides obtained at cleavage of 
the G-factor at the Asp-Pro bond included treatment 
with tluram [ 141 to exclude from the Edman reac- 
tion peptides with no proline residues at the N-ter- 
minus. 
The PTH-derivatives of ammo acids were identified 
by thin-layer chromatography on silica gel and HPLC 
(type HP 1080 A chromatograph) on a 5 pm Ultra- 
sphere RF-1 8 column in a sodium phosphate buffer 
using a methanol gradient. 
Amino acid sequences ofshort peptides were deter- 
mined by the dansyl Edman method [15]. Dansyl 
derivatives ofamino acids were identified by thin-layer 
chromatography on silica gel. Asparagine and giutamine 
were determined according to [6]. 
3. Results and discussion 
Studies of the kinetics of tryptic hydrolysis of the 
G-factor and determination ofthe N-terminal sequences 
in the fragments [2] have shown that fragment Te is 
the N-terminal one. Following it along the chain is 
fragment T, containing a functionally important cys- 
teine residue. The GTP-binding site is in the region of 
T T T T 
Arg Lys 
TS Id 
Fig.1. Arrangement of fragments of limited tryptic hydrolysis 
along the polypeptide chain of the G-factor. 
this fragment [171. Fragment T, is followed by frag- 
ment T, (M, 41000) and then by fragment TS which 
is the C-terminal part of the protein molecule (fig.1). 
The molecule contains 22 methionine residues and 
it could be therefore xpected that on cyanogen 
bromide cleavage 223 peptides would be formed. The 
scheme of cyanogen bromide hydrolyzate separation 
proposed by us has allowed us to isolate all the 23 
peptides. The mixture of peptides was modified by 
maleic anhydride and then separated on a Sephadex 
G-25 column. The fractions obtained were subjected 
to rechromatography onQAE-Sephadex A-25, and 
the fraction containing low molecular mass peptides 
was separated on thin-layer cellulose by peptide 
mapping. After chromatography on QAE-Sephadex 
A-25 the fractions were subjected once again to re- 
chromatography on QAE-Sephadex columns after a 
preliminary removal of the protecting maleic group. 
Of the 23 isolated peptides 10 peptides are included 
in fragment T4 while 2 peptides also involve some sites 
of polypeptide chains of fragments T, and Tg, and 
one peptide overlaps fragments T6 and T, (scheme 1). 
Thus, the study of the structure of fragment T, 
becomes the determination ofthe amino acid sequences 
of the 12 peptides of cyanogen bromide cleavage and 
the search for the overlaps between them. The struc- 
ture studies of these peptides have required their addi- 
tional cleavage by chemical or enzymic methods. 
To obtain overlapping peptides we have used tryp- 
tic digest of fragment T, after its modification with 
maleic anhydride, digest by StaphyZococcus rrureus 
protease and cleavage of the G-factor at the Asp-Pro 
bond. There are 3 such bonds in the molecule. Studies 
of the N-terminal sequences of the formed peptides 
by the automated Edman method with the use of 
fluram as a reagent blocking the primary cr-amino 
groups have allowed us to obtain overlaps between 
the peptides from CBG-13-CBG17 (scheme 1) and 
thus to reliably incorporate fragments T, and Ts into 
one polypeptide chain. 
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Scheme 1 
Complete primary structure of elongation factor G 
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Solid lines indicate only cyanogen bromide peptides of EF-G and the overlapping peptides 
obtained from other hydrolyses of T,-T, fragments of EF-G. Fragments of limited tiYPsinOIYSiS 
occupy the following positions in the polypeptide chain: Tb, l-58; T,, 59-127; T,, 128-471; 
T,, 472-699. CB, peptides of cyanogen bromide cleavage of EF-G. Ap, peptides of W-G 
hydrolysis at the Asp-Pro bond; T, peptides of tryptic hydrolysis of fragments T, and T,; LT, 
peptides of tryptic hydrolysis of fragments T, and T, modified at lysine residues; SP, peptides 
of Q&o&& of fragments T4 and T, by 5’. (iureus protease; Cys* = cysteine residues which 
form the S-S bond. 
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From the data of the amino acid analyses and deter- 
mination of the molecular mass of the fragments of 
limited tr~s~olys~ it can be concluded that trypsin- 
olysis does not lead to a nick of any essential regions 
of the polypeptide chain between these fragments 
[2]. Separation of the products of cyanogen bromide 
elongation factor cleavage resulted in the isolation of 
several peptides, and the dete~nation of their struc- 
tures allowed us to unite all the fragments of limited 
trypsinolysis (peptides CBG3, CBG-6 and CBG-17 in 
the scheme) into one polypeptide chain. There are no 
insertions between the fragments of limited trypsin- 
olysis, i.e., trypsin makes point ~s~ptions in the 
elongation factor G polypeptide chain [4]. We demon- 
strated [2] that all the fragments of limited trypsin- 
olysis have arginine as the C-terminal amino acid resi- 
due, whereas the C-terminal amino acid residue of 
EF-G is lysine. A structural study of the peptide 
CBG23 showed that is elongated by two amino acid 
residues Gly-Lys as compared with the corresponding 
peptide of cyanogen bromide cleavage of fragment 
T5 [ 71. Thus, we have concluded that the cleavage of
the C-terminal dipeptide is the result of limited tryp 
sinolysis of the G-factor. 
Thus, the study of fragments of limited trypsin- 
olysis of the G-factor and the products of cyanogen 
bromide cleavage and hydroly~ at the Asp-Pro bond 
of the G-factor have allowed us to report the com- 
plete amino acid sequence of the protein. Its polypep 
tide chain consists of 701 amino acid residues, has 
Mr 77 321.46 and contains 5 cysteine residues, two 
of which positions 296 and 392 in the scheme) form 
the S-S bond. To fmd the positiqn of the S-S bond, 
the G-factor was treated with Elman’s reagent (to pro- 
tect the SH-groups from oxidation) then subjected t’o 
cyanogen bromide cleavage. After removal of the pro- 
tecting group the products of cyanogen bromide cleav- 
age were chromatographed ona thiol-activated Seph- 
arose 4B column. After removal of thiol-containing 
peptides from Sepharose they were carboxymethylated, 
then reduced by sodium sulphite and again carboxy- 
methylated by ~4C-labe~ed ICH&OOH. The cysteine 
residues containing the radioactive label were found 
in peptides CBG-12 and CBG13 (scheme 1). This 
technique provided the isolation of all thiol-contain- 
ing peptides of the elongation factor G. 
These data on the primary structure of the G-factor 
agree with the data of other laboratories where the 
structure of some sites of the gene encoding the Gfac- 
tor has been determined. In particular, studies of 
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E. coli str-operon permitted the nucleotide sequence 
corresponding to 92 amino acid residues from the 
N-terminus of the Gfactor to be established [la], 
while dete~~tion of the nucleotide sequence of 
the tufA gene encoding the elongation factor Tu 
allowed the structure of the fus gene region which 
encodes the C-terminal part of the G-factor consisting 
of 20 amino acid residues [ 191 to be elucidated. In 
both cases the amino acid sequences established by a 
direct method and those derived from structure studies 
of DNA completely coincide. 
Elucidation of the primary structure of the Gfac- 
tor will permit the regularities of the re~tions~p 
between the structure and biological function to be 
studied on an entirely new basis. A new possibility 
appears for the study of the tertiary structure of the 
G-factor by X-ray structural analysis as large enough 
crystals have been obtained [20,21] completely 
including the protein polypeptide chain. 
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